1. Home
  2. PAVM vs CYCN Comparison

PAVM vs CYCN Comparison

Compare PAVM & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVM
  • CYCN
  • Stock Information
  • Founded
  • PAVM 2014
  • CYCN 2018
  • Country
  • PAVM United States
  • CYCN United States
  • Employees
  • PAVM N/A
  • CYCN N/A
  • Industry
  • PAVM Medical/Dental Instruments
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAVM Health Care
  • CYCN Health Care
  • Exchange
  • PAVM Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • PAVM 8.0M
  • CYCN 8.4M
  • IPO Year
  • PAVM 2016
  • CYCN N/A
  • Fundamental
  • Price
  • PAVM $0.79
  • CYCN $3.12
  • Analyst Decision
  • PAVM Strong Buy
  • CYCN
  • Analyst Count
  • PAVM 1
  • CYCN 0
  • Target Price
  • PAVM $19.00
  • CYCN N/A
  • AVG Volume (30 Days)
  • PAVM 195.9K
  • CYCN 5.8M
  • Earning Date
  • PAVM 03-25-2025
  • CYCN 03-04-2025
  • Dividend Yield
  • PAVM N/A
  • CYCN N/A
  • EPS Growth
  • PAVM N/A
  • CYCN N/A
  • EPS
  • PAVM 0.53
  • CYCN N/A
  • Revenue
  • PAVM $4,034,000.00
  • CYCN $194,000.00
  • Revenue This Year
  • PAVM $52.90
  • CYCN N/A
  • Revenue Next Year
  • PAVM $248.84
  • CYCN N/A
  • P/E Ratio
  • PAVM $1.50
  • CYCN N/A
  • Revenue Growth
  • PAVM 166.27
  • CYCN N/A
  • 52 Week Low
  • PAVM $0.57
  • CYCN $1.27
  • 52 Week High
  • PAVM $3.50
  • CYCN $9.47
  • Technical
  • Relative Strength Index (RSI)
  • PAVM 64.34
  • CYCN 46.78
  • Support Level
  • PAVM $0.62
  • CYCN $2.81
  • Resistance Level
  • PAVM $0.79
  • CYCN $4.80
  • Average True Range (ATR)
  • PAVM 0.07
  • CYCN 0.76
  • MACD
  • PAVM 0.02
  • CYCN -0.08
  • Stochastic Oscillator
  • PAVM 95.00
  • CYCN 20.76

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: